Press releases

image of papers

Key Capital to Distribute Novel Immune Supplement

NEW YORK, NY, January 28, 2021 – KEY CAPITAL CORPORATION (OTC Pink: KCPC) advises that as SARS-CoV-2 continues to spread, and reports of increases in daily infections, hospitalizations, and deaths are becoming regular, Key Capital plans to market its Immunitor partnered potentially therapeutic oral pill as a supplement commencing early February.

Read More »
newsimage

Key Capital Licenses Immunitor Oral Pill Immunotherapeutics

New York, NY November 23, 2020 – KEY CAPITAL CORPORATION (OTC Pink: KCPC) advises that Key Biotec, a division of Key Capital, has entered into agreement with Immunitor group interests (“Immunitor”) to exclusively license its breakthrough patented oral tableted immunotherapeutics platform products for North, Central and South America (excluding Canada), the EU (excluding UK), Australia and New Zealand (the “Territory”).

Read More »